Safety and Efficacy Conerns in the Use of Intravitreal Anti-VEGF Therapy (Sponsored)

April 6, 2015

This supplement to Ophthalmology Times is sponsored by CME Matters, LLC, and supported by an unrestricted grant from Regeneron Pharmaceuticals, Inc.

 

Safety and Efficacy Conerns in the
Use of Intravitreal Anti-VEGF Therapy

The Historical Perspective on
Efficacy and Systemic Safety


This supplement to Ophthalmology Times is sponsored by CME Matters, LLC, and supported by an unrestricted grant from Regeneron Pharmaceuticals, Inc.